1. Des-gamma-carboxy prothrombin as an important prognostic indicator in patients with small hepatocellular carcinoma
   Kenichi Hakamada et al, 2008, World Journal of Gastroenterology CrossRef
2. Evaluation of the Combined Application of AFP, AFP-L3%, and DCP for Hepatocellular Carcinoma Diagnosis: A Meta-analysis
   Xueying Wang et al, 2020, BioMed Research International CrossRef
3. Clinical utility of simultaneous measurement of alpha-fetoprotein and des-γ-carboxy prothrombin for diagnosis of patients with hepatocellular carcinoma in China: A multi-center case-controlled study of 1,153 subjects
   Peipei Song et al, 2014, BioScience Trends CrossRef
4. Evaluation of Virtual CT Sonography for Enhanced Detection of Small Hepatic Nodules: A Prospective Pilot Study
   Eisuke Okamoto et al, 2010, American Journal of Roentgenology CrossRef
5. Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinoma
   Pei-Pei Song, 2016, World Journal of Gastroenterology CrossRef
6. Perspectives on a combined test of multi serum biomarkers in China: Towards screening for and diagnosing hepatocellular carcinoma at an earlier stage
   Keming Zhang et al, 2014, Drug Discoveries & Therapeutics CrossRef
7. The Emerging Influences of Alpha-Fetoprotein in the Tumorigenesis and Progression of Hepatocellular Carcinoma
   Ye Xu et al, 2021, Cancers CrossRef
8. Serum Proteomics and Biomarkers in Hepatocellular Carcinoma and Chronic Liver Disease
   Noah T. Zinkin et al, 2008, Clinical Cancer Research CrossRef
9. Circulating predictive and diagnostic biomarkers for hepatitis B virus-associated hepatocellular carcinoma
   Stijn Van Hees et al, 2016, World Journal of Gastroenterology CrossRef
10. Identification of Cystatin B as a Potential Serum Marker in Hepatocellular Carcinoma
    Mi-Jin Lee et al, 2008, Clinical Cancer Research CrossRef